[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
:: Volume 13, Issue 3 (Summer 2022) ::
Caspian J Intern Med 2022, 13(3): 519-526 Back to browse issues page
HOMA-IR index in non diabetic patient, a reliable method for early diagnosis of liver steatosis
Behrang Motamed , Mahsa Kohansal Vajargah , Saeed Kalantari , Afshin Shafaghi *
GI Cancer Screening and Prevention Research Center, Guilan University of Medical Sciences, Rasht, Iran , drafshinshafaghi@gmail.com
Abstract:   (412 Views)
Background: NAFLD is one of the most common liver diseases in the world. HOMA-IR as an indicator of insulin resistance is commonly used in clinical trials in NAFLD patients. The aim of this study was to evaluate the application of HOMA-IR index in the diagnosis of NAFLD.
Methods: This study was performed on 54 patients with NAFLD and 54 non-NAFLD patients that referred to Razi Hospital in Rasht during 2019-2020. FibroScan was used to diagnose NAFLD in the patient group and ultrasound was used to rule it out in the control group. Metabolic and hepatic parameters were measured for each patient. Data were entered into SPSS 22 software and the necessary analyses were performed.
Results: The mean age of the subjects in the study was 44.01±13.12 years and ranged from 18 to 75 years. 72.2% of people affected by NAFLD were men (p <0.001) .The optimal cut-off point for HOMA-IR in NAFLD was 1.65 with a sensitivity of 89.7% and a specificity of 76.9% in men and 1.90 with a sensitivity of 86.7% and a specificity of 82.9% in women. Overall, the optimal cut-off point for HOMA-IR in NAFLD was 1.75 with a sensitivity of 87.0% and a specificity of 81.5%. In addition, the results showed that there was no significant relationship between steatosis and hepatic fibrosis with HOMA-IR index.
Conclusion: The results showed that HOMA-IR can be used as a reliable criterion for early detection of NAFLD.
Keywords: NAFLD, HOMA-IR, insulin resistance, FibroScan, BMI.
Full-Text [PDF 239 kb]   (171 Downloads)    
Type of Study: Original Article | Subject: Gastroentrology
Received: 2021/01/6 | Accepted: 2021/03/17 | Published: 2022/06/1
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA



XML     Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Motamed B, Kohansal Vajargah M, Kalantari S, Shafaghi A. HOMA-IR index in non diabetic patient, a reliable method for early diagnosis of liver steatosis. Caspian J Intern Med. 2022; 13 (3) :519-526
URL: http://caspjim.com/article-1-2695-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 13, Issue 3 (Summer 2022) Back to browse issues page
Caspian Journal of Internal Medicine
Persian site map - English site map - Created in 0.05 seconds with 30 queries by YEKTAWEB 4419